This federal contract award is for the delivery of GEMTESA 75 MG TABLET 30S, pharmaceutical products, to the Defense Logistics Agency (DLA). The $9,337.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.
The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This particular delivery order does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of November 27, 2024.
Generated 2/25/25, 10:11 AM